Hims & Hers Health (HIMS) is trading at $18.54, down 3.08% on the day and below its short-, medium-, and long-term moving averages. The latest analyst updates were mixed, but the median of the name...
Hims & Hers Health (HIMS) is under pressure near the lower end of its recent range, with the stock at $18.54 after a 3.08% decline over the last 24 hours. The trading range printed between $19.17 and $18.27, while volume on Binance futures was light at $1.19 million, pointing to a pullback that has not yet shown strong participation from the buy side.
The analyst backdrop on November 10, 2026 was mixed but clearly less aggressive than before. Morgan Stanley cut its target to $25 from $28 and kept an Equal-Weight rating. Needham lowered its target to $32 from $42 while staying Buy. Evercore ISI raised its target to $27 from $24 and held an In-Line rating. Jefferies cut its target to $24 from $31 and kept Hold. Canaccord Genuity reiterated Buy and held its $40 target after third-quarter results.
The chart remains in a bearish alignment, with the 7-day simple moving average at $19.35 below the 20-day at $23.40 and the 50-day at $26.77. The stock is also trading below both the 12-day EMA at $20.89 and the 26-day EMA at $23.39, which keeps the short- and intermediate-term trend pointed lower.
Momentum is stretched. 78, which places HIMS in oversold territory. 07 reinforce that the stock is deeply compressed. 0000, which suggests downside momentum is still present even if the move is already extended.
Source link







